POLSINELLI PC

POLSINELLI PC filed a Q3 report for TONIX PHARMACEUTICALS on October 8, 2026, reporting $20,000 in lobbying income.

Lobbying for TONIX PHARMACEUTICALS · clinical stage biopharmaceutical co developing drugs for central nervous system conditions

All filings by POLSINELLI PC · Everything TONIX PHARMACEUTICALS has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 8, 2026

Income

$20,000

What the client paid this registrant for the period.

Client based in

New Jersey

Official filing document

Government bodies contacted 2

HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

Issues related to access to non-opioid alternatives

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.